Bristol Myers Squibb Integrates AI to Enhance Drug Development Processes
Bristol Myers Squibb is introducing Anthropic's Claude AI model to over 30,000 employees, seeking to reshape drug development and streamline operations.
More from this archive
Can Google Elevate AI Agents Beyond Concepts to Useful Tools?
As Google rolls out Gemini Spark, the tech giant hopes to redefine AI agents from theoretical concepts to…
Jeff Bezos Dismisses AI Bubble Fears, Predicts Long-Term Growth
At Italian Tech Week 2025, Jeff Bezos addressed AI bubble concerns, emphasizing the long-term benefits of substantial investments…
Bristol Myers Squibb Expands AI Capabilities with Anthropic’s Claude
Bristol Myers Squibb is set to enhance its AI initiatives by deploying Anthropic’s Claude platform to over 30,000…
Bristol Myers Squibb Partners with Anthropic to Boost Drug Discovery
Bristol Myers Squibb has partnered with Anthropic to deploy the Claude AI model across its workforce, aiming to…
The archive
sorted by latest
Anthropic Introduces Claude for Small Business with 15 Workflows
GPUBeat Desk · 2 min
Tenable Partners with Anthropic to Enhance AI Offerings
GPUBeat Desk · 2 min
Alibaba Launches Zhenwu M890 AI Chip Amid U.S. Export Challenges
GPUBeat Desk · 3 min
Bristol Myers Squibb Integrates Claude AI for Enhanced Drug Discovery
GPUBeat Desk · 2 min
Eurovision 2026 Sparks Controversy Amid Celebrity Headlines
GPUBeat Desk · 2 min